Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population

Documenti analoghi

• External validation of the United Kingdom‐primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid
  di: Cheung, Angela C., et al.
  Pubblicazione: (2018)
• Prevalence and Predictors of Gastrointestinal Dysmotility in Patients with Hypermobile Ehlers-Danlos Syndrome: A Tertiary Care Center Experience
  di: Alomari, Mohammad, et al.
  Pubblicazione: (2020)
• Predictive Model of Ursodeoxycholic Acid Treatment Response in Primary Biliary Cholangitis
  di: Shu, Yanyun, et al.
  Pubblicazione: (2021)
• Prolonged Follow-Up of Patients in the U.S. Multicenter Trial of Ursodeoxycholic Acid for Primary Biliary Cirrhosis
  di: Combes, Burton, et al.
  Pubblicazione: (2004)
• Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis
  di: Zimmer, Vincent, et al.
  Pubblicazione: (2016)